Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. - Vogel,V.G.; Costantino,J.P.; Wickerham,D.L.; Cronin,W.M.; Cecchini,R.S.; Atkins,J.N. (JAMA, 2006)